title: Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist.
abstract: OBJECTIVE
  To assess the long-term effects of GnRH agonist (GnRH-a) therapy in a patient with benign ovarian hyperandrogenism.
  
  
  METHODS
  Case report.
  
  
  METHODS
  University Hospital endocrine outpatient's clinic.
  
  
  METHODS
  A 55-year-old postmenopausal woman with hirsutism and virilization of ovarian origin.
  
  
  METHODS
  Treatment with a course of GnRH-a (triptorelin 3.75 mg IM every 28 days for 4 months). Follow-up for 3 years.
  
  
  METHODS
  Serum gonadotropin and androgen levels, clinical assessment using the Ferriman-Gallwey score, and assessment of ovarian morphology by ultrasonography.
  
  
  RESULTS
  Administration of triptorelin resulted in suppression of serum testosterone and gonadotropin values and relief of the hyperandrogenic symptoms. Upon discontinuation of treatment, the patient's serum gonadotropin levels returned to the postmenopausal range, but the testosterone levels remained normal and the patient was asymptomatic for an observation period of 3 years.
  
  
  CONCLUSIONS
  This case is the first example of long-term remission of ovarian hyperandrogenism in a postmenopausal woman, after short-term treatment with GnRH-a. This supports the view that GnRH-a therapy could be used, even in short courses, for the long-term suppression of benign ovarian hyperandrogenism.
authors.affiliation: Endocrine Unit, Department of Medicine, University Hospital of Ioannina, Ioannina, Greece.
authors.forename: Z
authors.initials: Z
authors.lastname: Efstathiadou
authors.forename: A
authors.initials: A
authors.lastname: Tsatsoulis
mesh_terms: D000324:Adrenocorticotropic Hormone; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006062:Gonadotropins / Q000097:blood; D006628:Hirsutism / Q000209:etiology; D006728:Hormones / Q000097:blood; D006801:Humans; D017588:Hyperandrogenism / Q000188:drug therapy*; D008875:Middle Aged; D010049:Ovarian Diseases / Q000188:drug therapy*; D013739:Testosterone / Q000097:blood; D013997:Time Factors; D017329:Triptorelin Pamoate / Q000627:therapeutic use*
chemical_list: D006062:Gonadotropins; D006728:Hormones; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D000324:Adrenocorticotropic Hormone